StockData

Oaktree Acquisition Corp. III Life Sciences (OACC) stock

OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.00 (0.00%)

Close on Nov 18, 2026Market cap $263.53MP/E –Yield –

Oaktree Acquisition Corp. III Life Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Oaktree Acquisition Corp. III Life Sciences's operating income for the twelve months ending Jun 30, 2026 was -$1.20M. For fiscal 2025 it was -$1.20M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.20M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$261.96K–
Q1 FY2026Mar 31, 2026-$456.54K–
Q4 FY2025Dec 31, 2025-$255.50K–
Q3 FY2025Sep 30, 2025-$225.58K–
Q2 FY2025Jun 30, 2025-$269.81K–
Q1 FY2025Mar 31, 2025-$444.80K–
Q3 FY2024Sep 30, 2024-$48.10K–

More Oaktree Acquisition Corp. III Life Sciences figures

See a number that looks wrong?